


Four Startups Advance to Spring 2023 George Shultz Innovation Fund Finals
Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic
A Gut Check for Post-Op Infection: Covira Offers a Pro-Bacteria Approach
How Technology Commercialization Teams Are Thinking Differently
Quantum Startup memQ Raises $2 Million Seed Round to Shape the Future of Quantum Networking
Novel Device Helps Eliminate Smoke in the Operating Room, a Workplace Hazard for Surgical Teams
Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund
Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund
UChicago Launches Polsky Deep Tech Ventures to Support Startups Bringing Science, Tech to Market
Newly Discovered Electrolyte Could Be The Answer To Lithium-Ion Storage Capacity, Stability
Digital Health, Therapeutics Startups Selected for George Shultz Innovation Fund Finals
ClostraBio Closes $4 Million Series A to Transform Intestinal Health with Plug-and-Play Drug Delivery Platform
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.